ScinoPharm Taiwan, Ltd.

NT$20.15As of Sun 8 Nov 2026, 12:00 UTC
TWSE:1789Healthcare
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR (4.91%)
Div yield 1.44%
ROE 0.15%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.39
PE TTM 1,132
TSR TTM 16.45%
Mkt cap NT$15.93B
ROIC (1.33%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$25
22.09%
(46.91%)
Hold 12|10|12|1|8
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.36
0.35
0.34
0.35
18.64%
14.38%
1.55%
4.19%
RevenueNT$B
1.208
1.221
1.216
1.254
9.12%
6.86%
5.18%
6.69%
Peers (US$481.2M)
Cap (US$)
PE
473.0M
17.48x
444.5M
17.80x
Capital
TTM
5Y
10Y
Leveragex
0.734
0.012
0.024
EBIT/Intx
2.539
0.170
0.215
Own earn%
(4.26)
(31.51)
(28.33)
Sh yield%
15.42
21.32
20.56
Owners
Insiders/Inst%
0.94
72.81
Short interest%
5.70
SBC / revenue%
1.31
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
9
Op margin range%
17–23
$1 testx
—
Incr. ROIC%
0